| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/26/2004 | WO2003039245A3 Transgenic mice knockout for histamine receptor h3 gene |
| 02/26/2004 | WO2003037247A3 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003030719A3 Methods and kits for use in selecting approaches to treating cancer |
| 02/26/2004 | WO2003029412A3 Restricted expression lentivial vectors |
| 02/26/2004 | WO2003029400A3 Cell lines for productive infection of hepatitis b virus |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | WO2003015708A3 Composition and method for treating hiv infection |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2003002711A3 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002099047A3 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/26/2004 | WO2002089737A8 Separation of platelets from whole blood for use as a healant |
| 02/26/2004 | WO2002087411A3 Composite scaffolds and methods using same for generating complex tissue grafts |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002074921A3 Methods for isolating proteins expressed by dendritic cells |
| 02/26/2004 | WO2002069988A3 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 02/26/2004 | WO2002068600A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/26/2004 | WO2002062204A3 Methods for diagnosing and treating heart disease |
| 02/26/2004 | WO2002059263A3 Transgenic animals comprising a humanized immune system |
| 02/26/2004 | WO2002051237A3 Helicobacter proteins, nucleic acids and uses thereof |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2001074299A3 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040040062 Method for producing human lactoferrin in plant cell culture |
| 02/26/2004 | US20040040061 Corn for administration to animals to elicit immune respone; plant extracts |
| 02/26/2004 | US20040040059 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor BT-R2 |
| 02/26/2004 | US20040040052 Transgenic organism |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040040048 Introducing atransgene into an embryo of the animal, which containing a nucleic acid encoding phytase, transplanting the embroy into a pseudopregnanat animal, allowing embryo to develop to term, detecting offspring expressing the transgene |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039184 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040038926 Antisense modulation of MyD88 expression |
| 02/26/2004 | US20040038924 Adenovirus serotype 30 (Ad30) |
| 02/26/2004 | US20040038896 For diagnosis and therapy |
| 02/26/2004 | US20040038888 Functional role and potential therapeutic use of PACAP, VIP and Maxadilan in relation to adult neural stem or progenitor cells |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038430 Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 02/26/2004 | US20040038424 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 02/26/2004 | US20040038407 From plants having decreased content of anthocyanins; enzyme inhibitors |
| 02/26/2004 | US20040038405 Vectors and viral vectors, and packaging cell lines for propagating same |
| 02/26/2004 | US20040038403 Replication-defective; does not rely on use of tumor specific promoters |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038398 Purification and uses of dendritic cells and monocytes |
| 02/26/2004 | US20040038397 Comprises transfection of neuronal cells with oncogene expression vector; for increased phosphorylation of tau protein |
| 02/26/2004 | US20040038396 Antihemophilic factor (factor VIII) |
| 02/26/2004 | US20040038381 Comprises genetically engineered strains of Pichia; mannosidases; glycoproteins; kits |
| 02/26/2004 | US20040038374 Method for accessing microbial diversity |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038367 Which cleaves the second beta-glucoside linkage of xyloglucans; isolated from Geotrichum species |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038324 Epothilone resistant cell lines |
| 02/26/2004 | US20040038322 Preventing metastasis and tumor expression via gene expression inhibition of kruppel like transcription factor; antisense therapy; antitumor agents; gene silencing agents |
| 02/26/2004 | US20040038312 Identifying modulators of g-protein coupled receptor associated with taste/flavor transduction; food processing and artificial sweetners |
| 02/26/2004 | US20040038288 Human protein C Polypeptide |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038275 Human frezzled-like protein |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038247 Expression vector comprised of regulatory sequences for lymphocyte specific expression of heterologous polypeptides |
| 02/26/2004 | US20040038244 Comprises expression vector capable of chromosomal insertion and transcription of telomerase for generating transgenic somatic cells and screening and/or identifying antitumor and anticarcinogenic agents |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds |
| 02/26/2004 | US20040038205 Modified adenoviral fiber and uses |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038019 Microscopic networks of containers and nanotubes |
| 02/26/2004 | US20040037874 Delivery of nucleic acid-like compounds |
| 02/26/2004 | US20040037847 Assays for compounds that modulate rhadino virus lana action in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 02/26/2004 | US20040037845 Use of flt3-ligand in the treatment of infection |
| 02/26/2004 | US20040037843 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 02/26/2004 | US20040037841 Nucleic acid sequences that are expressed in chondrocytes from fetal, normal, mild osteoarthritic, moderate osteoarthritic, marked and osteoarthritic |
| 02/26/2004 | US20040037837 For stimulating CD8 T-cell response; tuberculosis vaccines; antigen presenting cells |
| 02/26/2004 | US20040037833 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040037819 Non-polymeric hematopoeitic cell clots for delivery of active agents |
| 02/26/2004 | US20040037818 Treatment for diabetes |
| 02/26/2004 | US20040037815 Isolation and use of solid tumor stem cells |
| 02/26/2004 | US20040037814 Comprises immature animal cells characterized by expression of alpha-fetoprotein and albumin; extracelluar matrix is formed from collagen, fibronectin, and laminin; solid phase synthesis; for liver transplants |
| 02/26/2004 | US20040037813 For production of organs for implantation; for inducing cell differentiation |
| 02/26/2004 | US20040037812 Flowable implantable composition comprising a support material, such as various forms of collagen or alginate beads or threads, which can support the attachment and growth of chondrocyte cells thereto, ad a method of making a flowable |
| 02/26/2004 | US20040037811 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/26/2004 | US20040037807 Generation and use of dendritic cells |